Beurel E - Search Results

1

Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.

Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J. Desbois-Mouthon C, et al. Among authors: beurel e. Hepatology. 2002 Dec;36(6):1528-36. doi: 10.1053/jhep.2002.37192. Hepatology. 2002. PMID: 12447879

2

GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression.

Beurel E, Kornprobst M, Blivet-Van Eggelpoël MJ, Ruiz-Ruiz C, Cadoret A, Capeau J, Desbois-Mouthon C. Beurel E, et al. Exp Cell Res. 2004 Nov 1;300(2):354-64. doi: 10.1016/j.yexcr.2004.08.001. Exp Cell Res. 2004. PMID: 15475000

3

GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis.

Beurel E, Kornprobst M, Blivet-Van Eggelpoël MJ, Cadoret A, Capeau J, Desbois-Mouthon C. Beurel E, et al. Int J Oncol. 2005 Jul;27(1):215-22. Int J Oncol. 2005. PMID: 15942663

4

Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.

Beurel E, Blivet-Van Eggelpoël MJ, Kornprobst M, Moritz S, Delelo R, Paye F, Housset C, Desbois-Mouthon C. Beurel E, et al. Biochem Pharmacol. 2009 Jan 1;77(1):54-65. doi: 10.1016/j.bcp.2008.09.026. Epub 2008 Oct 1. Biochem Pharmacol. 2009. PMID: 18938143

5

Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma.

Boissan M, Beurel E, Wendum D, Rey C, Lécluse Y, Housset C, Lacombe ML, Desbois-Mouthon C. Boissan M, et al. Among authors: beurel e. Am J Pathol. 2005 Sep;167(3):869-77. doi: 10.1016/S0002-9440(10)62058-5. Am J Pathol. 2005. PMID: 16127164 Free PMC article.

6

Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response.

Wang H, Brown J, Gu Z, Garcia CA, Liang R, Alard P, Beurel E, Jope RS, Greenway T, Martin M. Wang H, et al. Among authors: beurel e. J Immunol. 2011 May 1;186(9):5217-26. doi: 10.4049/jimmunol.1002513. Epub 2011 Mar 21. J Immunol. 2011. PMID: 21422248 Free PMC article.

7

Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells.

Beurel E, Yeh WI, Michalek SM, Harrington LE, Jope RS. Beurel E, et al. J Immunol. 2011 Feb 1;186(3):1391-8. doi: 10.4049/jimmunol.1003511. Epub 2010 Dec 29. J Immunol. 2011. PMID: 21191064 Free PMC article.

8

Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.

Beurel E, Kaidanovich-Beilin O, Yeh WI, Song L, Palomo V, Michalek SM, Woodgett JR, Harrington LE, Eldar-Finkelman H, Martinez A, Jope RS. Beurel E, et al. J Immunol. 2013 May 15;190(10):5000-11. doi: 10.4049/jimmunol.1203057. Epub 2013 Apr 19. J Immunol. 2013. PMID: 23606540 Free PMC article.

9

Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.

Beurel E, Jope RS. Beurel E, et al. J Neuroinflammation. 2009 Mar 11;6:9. doi: 10.1186/1742-2094-6-9. J Neuroinflammation. 2009. PMID: 19284588 Free PMC article.

10

Differential regulation of STAT family members by glycogen synthase kinase-3.

Beurel E, Jope RS. Beurel E, et al. J Biol Chem. 2008 Aug 8;283(32):21934-44. doi: 10.1074/jbc.M802481200. Epub 2008 Jun 11. J Biol Chem. 2008. PMID: 18550525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters